Oscar Health (NYSE:OSCR) Stock Price Down 4.6% - Should You Sell?

Key Points

• Oscar Health's stock price fell by 4.6% to $17.10 during mid-day trading, with a significant drop in trading volume by 73% compared to average daily levels.
• Recent analyst ratings show a bleak outlook, with a consensus average rating of "Strong Sell" and a lowered price target averaging $12.07.
• Despite reporting a revenue increase of 29% year-over-year, Oscar Health had a negative EPS of ($0.89) and missed the revenue consensus estimate by $0.02 billion for the last quarter.

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) were down 4.6% during trading on Wednesday . The company traded as low as $17.23 and last traded at $17.10. Approximately 3,681,499 shares traded hands during trading, a decline of 73% from the average daily volume of 13,805,328 shares. The stock had previously closed at $17.93.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on OSCR shares. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Robert W. Baird reiterated a "neutral" rating and issued a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. UBS Group reissued a "sell" rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Wall Street Zen cut shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Finally, Raymond James Financial cut shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Four research analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Stock Down 0.7%

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The firm's 50-day moving average price is $16.19 and its 200 day moving average price is $15.27. The firm has a market cap of $4.90 billion, a P/E ratio of -23.42 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. During the same quarter last year, the company posted $0.20 earnings per share. The company's quarterly revenue was up 29.0% compared to the same quarter last year. On average, equities research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently bought and sold shares of OSCR. BNP Paribas Financial Markets bought a new position in Oscar Health in the fourth quarter worth about $590,000. Cetera Investment Advisers lifted its holdings in Oscar Health by 17.1% in the fourth quarter. Cetera Investment Advisers now owns 27,066 shares of the company's stock worth $364,000 after acquiring an additional 3,961 shares during the last quarter. Deutsche Bank AG lifted its holdings in Oscar Health by 51.2% in the fourth quarter. Deutsche Bank AG now owns 172,127 shares of the company's stock worth $2,313,000 after acquiring an additional 58,282 shares during the last quarter. Nuveen Asset Management LLC lifted its holdings in Oscar Health by 1.0% in the fourth quarter. Nuveen Asset Management LLC now owns 2,356,298 shares of the company's stock worth $31,669,000 after acquiring an additional 23,237 shares during the last quarter. Finally, ProShare Advisors LLC increased its stake in shares of Oscar Health by 52.7% in the fourth quarter. ProShare Advisors LLC now owns 56,098 shares of the company's stock valued at $754,000 after purchasing an additional 19,356 shares during the period. Institutional investors own 75.70% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.